Evidence map›Paper›PMID 41128677›Full record

ArticleBJPsych open2025

Psychiatrists and non-psychiatrists' attitudes to psychotropic optimisation for people with intellectual disabilities and/or autism: cross-sectional comparison study.

Samuel J Tromans, Shoumitro Deb, Hassan Mahmood, Paraskevi Triantafyllopoulou, Tony Jamieson, Gill Gookey, Paul Bassett, Zayed Malak, Indermeet Sawhney, Laura Korb and 3 more

Abstract read
In one paragraph

Article in BJPsych open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Samuel J TromansSAPPHIRE Group, Department of Population Health Sciences, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0002-0783-285X
Shoumitro DebImperial College London, London, UK.ORCID https://orcid.org/0000-0002-1300-8103
Hassan MahmoodCoventry and Warwickshire Partnership Trust, Birmingham, UK.
Paraskevi TriantafyllopoulouTizard Centre, University of Kent, Canterbury, UK.
Tony JamiesonNHS England, Nottingham, UK.
Gill GookeyNHS England, Nottingham, UK.
Paul BassettHealth Innovation East Midlands, Nottingham, UK.
Zayed MalakTizard Centre, University of Kent, Canterbury, UK.
Indermeet SawhneyHertfordshire Partnership University NHS Foundation Trust, Hatfield, UK.
Laura KorbBarnet, Enfield and Haringey Mental Health NHS Trust, London, UK.ORCID https://orcid.org/0000-0002-0084-1665
Danielle AdamsUniversity of Warwick, Coventry, UK.ORCID https://orcid.org/0000-0002-7705-9540
Rory SheehanKing's College London, London, UK.
Rohit ShankarUniversity of Plymouth, Plymouth, UK.ORCID https://orcid.org/0000-0002-1183-6933

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOff-licence psychotropic use in people with intellectual disability and/or autism, in the absence of psychiatric illness, is a major public health concern in England.

aimsTo ascertain and compare views of psychiatrists and non-psychiatrists working with people with intellectual disability and/or autism on psychotropic medication optimisation for this population.

methodA cross-sectional survey of 13 questions was disseminated online among psychiatrists and other health professionals working with people with intellectual disability and/or autism across England, using a non-discriminatory exponential snowballing technique leading to non-probability sampling. The questionnaire covered demographic characteristics, perceived barriers/benefits of psychotropic optimisation (including ethnicity) and views on implementation of a national medicine optimisation programme. Quantitative analysis used chi-squared, Mann-Whitney and unpaired

resultsOf 219 respondents, significant differences in attitudes to most issues emerged between psychiatrists (

conclusionsThis is the first study to highlight important differences between psychiatrists and non-psychiatrists' attitudes to psychotropic optimisation despite respondents overall being broadly supportive of its need. A major finding is the hitherto unquantified concerns of patient ethnicity and its impact on psychotropic optimisation principles.

Indexed as

antipsychoticautismIntellectual disabilitypsychiatrypsychotropic

Identifiers

PMID41128677
PMCPMC12569613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.